32,864
Participants
Start Date
December 5, 2023
Primary Completion Date
January 15, 2024
Study Completion Date
March 10, 2024
Azvudine
Antiviral drug
Paxlovid
Antiviral drug
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Henan Provincial Chest Hospital
OTHER
The Affiliated Infectious Disease Hospital of Zhengzhou University
UNKNOWN
The Fifth People's Hospital of Anyang
UNKNOWN
Shangqiu Municipal Hospital
UNKNOWN
Nanyang Central Hospital
OTHER
Luoyang Central Hospital
OTHER
Guangshan County People's Hospital
UNKNOWN
Fengqiu County People's Hospital
UNKNOWN
The First Affiliated Hospital of Zhengzhou University
OTHER